Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other financing activities (2020 - 2023)

Rockwell Medical (RMTI) has disclosed Other financing activities for 4 consecutive years, with -$38000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to -$38000.0, compared with a TTM value of $5000.0 through Dec 2024, changed 0.0%, and an annual FY2023 reading of $5000.0, down 95.28% over the prior year.
  • Other financing activities was -$38000.0 for Q4 2023 at Rockwell Medical, down from $43000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $969000.0 in Q2 2020 and bottomed at -$38000.0 in Q4 2023.
  • Average Other financing activities over 3 years is $269675.6, with a median of $43000.0 recorded in 2023.